17.08.2011 • News • Mergers & Acquisitions (M&A) • portfolio • Pharmaceuticals

Becton, Dickinson and Co. Completes Acquisition Of Carmel Pharma

Becton, Dickinson and Co. announced the completion of its acquisition of Carmel Pharma, a Swedish company that manufactures the PhaSeal System.

The company said that it expects fully diluted earnings per share to be adversely impacted by the acquisition in fiscal year 2011 by approximately $0.05, which was not included in the fiscal year 2011 earnings guidance the Company provided in connection with the release of its third fiscal quarter earnings.

Virtual Event

CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.